Menopause-Associated Vasomotor Symptom Treatment With Elinzanetant
8/22/2024
0:00
11:25
Nonhormonal treatments for menopausal vasomotor symptoms may benefit symptomatic patients who cannot take or prefer to avoid systemic hormones. Author JoAnn V. Pinkerton, MD, MSCP, discusses the efficacy and safety of elinzanetant for the treatment of moderate to severe vasomotor symptoms associated with menopause with JAMA Deputy Editor Linda Brubaker, MD, MS.
Related Content:
More episodes from "JAMA Author Interviews"
Don't miss an episode of “JAMA Author Interviews” and subscribe to it in the GetPodcast app.